Our rationale for inclusion of the IFNß gene in the virus was both to enhance safety by shutting down of viral replication in off target non tumor tissues, and to provide further immune stimulatory signals for the activation of anti-tumor T cell responses. This evidence concerns the gene IFNA1 and neoplasm.